Keyphrases
Glutamate Receptors
100%
Parkinson's Disease
100%
Receptor Gene
100%
Coffee
100%
Modifier Genes
100%
Gene-environment
100%
Disease Modifier
100%
Environment Studies
100%
GRIN2A
100%
Genome-wide Association Study
81%
Drinkers
72%
Genome-wide Interaction Study
45%
SNP
27%
Clinical Trials
18%
Low Risk
18%
Research Consortium
18%
Neurogenetics
18%
CC Genotype
18%
Inverse Association
9%
Genotype
9%
Environmental Factors
9%
Caffeine
9%
Excitatory Neurotransmission
9%
Glutamate Receptor Antagonists
9%
Region of Interest
9%
Disease Genes
9%
Genotype Data
9%
Pharmacodynamic Biomarker
9%
Receptor Subunits
9%
Coffee Consumption
9%
Adenosine Receptor Antagonists
9%
Parkinson's Disease Risk
9%
Significant SNPs
9%
Consumption Data
9%
Caffeinated Coffee
9%
NMDA Glutamate Receptors
9%
Study Replication
9%
Genomic Coverage
9%
Biochemistry, Genetics and Molecular Biology
Receptor Gene
100%
Modifier Gene
100%
Glutamate Receptor
100%
GRIN2A
100%
Genome Wide Association Study
83%
Interaction Study
83%
Genome-Wide Association Study
66%
Single Nucleotide Polymorphism
66%
Genotyping
66%
Clinical Trial
33%
Neurogenetics
33%
Pharmacogenetics
16%
Lifespan
16%
Synaptic Transmission
16%
Adenosine Receptor Antagonist
16%
Genomics
16%
Glutamic Acid
16%
N-Methyl-D-Aspartic Acid
16%
Neuroscience
Glutamate Receptor
100%
Parkinson's Disease
100%
Receptor Gene
100%
Modifier Gene
100%
GRIN2A
100%
Genome-Wide Association Study
66%
Glutamic Acid
16%
N-Methyl-D-Aspartic Acid
16%
Receptor Subunit
16%
Synaptic Transmission
16%
Treatment of Parkinson's Disease
16%
Adenosine Antagonists
16%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Receptor Gene
100%
Genome-Wide Association Study
100%
Modifier Gene
100%
Replication
50%
Lifespan
25%
Synaptic Transmission
25%
Pharmacogenetics
25%
Susceptibility
25%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Glutamate Receptor
100%
Clinical Trial
28%
Pharmacogenetics
14%
Receptor Subunit
14%
Disease Predisposition
14%
Glutamate Receptor Antagonist
14%
N Methyl Dextro Aspartic Acid
14%
Adenosine Receptor Blocking Agent
14%